Patient Recruitment/Retention Featured Articles

  1. Pelage Embraces Diverse Patient Recruitment For Non-Hormonal Hair Loss Therapy 9/5/2024

    Pelage Pharmaceuticals’ CMO Qing Yu Christina Weng, MD discusses how the company expanded criteria to include patients of all skin and hair types and incorporate decentralized elements in their trial design for a novel hair loss treatment.

  2. More Diverse Enrollment Means More Attention To I/E Language 9/4/2024

    Clinical research nurse Teri Crumb, MSN, RN, CCRC picks out a few potentially problematic inclusion/exclusion (I/E) criteria and details ways to address them.

  3. Navigating A Rare Disease Clinical Trial: A Patient And Family Perspective 9/3/2024

    Becky Vivian shares her inspiring story, offering readers valuable insights into the unique challenges faced by caregivers of rare disease patients.

  4. 3 Surefire Ways To Design Trials That Patients Want And Need 9/3/2024

     

    Alpha Tau Medical CMO Robert Den, MD details three ways sponsors can more effectively design clinical trials with patients in mind.

     

  5. A Vision For Inclusion: Designing Trials That Benefit Visually Impaired Patients 8/30/2024

    Ocugen CMO Huma Qamar, MD, MPH, CMI contends that whether targeting vision-related conditions or other medical needs, sponsors must design trials that ensure vision-impaired patients are included.

  6. The DCT Revolution Is Over… Vive La DCT Evolution! 8/29/2024

    The DCT ecosystem has matured significantly to include service providers with more real-world experience and advanced tools, plus a mindset of initiative versus reaction. Numerous regulators have released or updated DCT guidance documents in recent years, too, putting the onus on the industry to provide actionable feedback on those drafts.

  7. The DEI Dilemma: Separate Teams Or Embedded Methods? 8/28/2024

    Denise Bronner, PH.D. examines the advantages and drawbacks of separate, dedicated DEI teams and diversity roles embedded across functional areas.

  8. Summing Up The FDA's Long-Anticipated Draft Guidance On Diversity Action Plans 8/26/2024

    Life sciences attorney Marylana Saadeh Helou summarizes the FDA's draft guidance on Diversity Action Plans (DAPs).

  9. How Sponsors Can Make It Easier For Rare Disease Patients And Families To Participate In Trials 8/22/2024

    New research highlights several significant challenges sponsors encounter when conducting clinical trials in rare neurological disorders.

  10. Individual Participant Data Return Solutions And Strategies 8/22/2024

    Paula Boyles, external clinical trial data-sharing program lead for Pfizer and TransCelerate BioPharma member, shares the benefits of and strategies for individual patient data return (iPDR).